La catena delle opzioni mostra i dati chiave delle opzioni azionarie di IM Cannabis a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per IM Cannabis..

IM Cannabis (NASDAQ:IMCC) Azioni, Catena delle Opzioni

IM Cannabis

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

IM Cannabis Corp

IM Cannabis announces $1.61M private placement offering

IM Cannabis Corp (TSE:IMCC) has released an update. IM Cannabis Corp. has announced a planned private placement offering aimed at raising up to US$...

IM Cannabis Corp. Plans Private Placement and Restructures Incentives

Tilray Q1 Preview: Germany Could Drive Earnings Surprise

IM Cannabis Corp (TSE:IMCC) has released an update. IM Cannabis Corp reported a significant 50% increase in revenue in its German subsidiary follow...

IM Cannabis Corp: Revenue Surge and Expansion Plans

IM Cannabis Corp (TSE:IMCC) has released an update. IM Cannabis Corp., a prominent player in the medical cannabis market in Israel and Germany, is ...

IM Cannabis to Announce Q3 2024 Financial Results

IM Cannabis Corp (TSE:IMCC) has released an update. IM Cannabis Corp reported a 12% increase in revenue and a 16% reduction in operating expenses f...

IM Cannabis Reports Revenue Growth and Efficiency Gains

IM Cannabis GAAP EPS of -$0.41, revenue of $13.9M

IM Cannabis Corp. (IMCC) Q3 2024 Earnings Call Transcript

IM Cannabis Corp. 2024 Q3 - Results - Earnings Call Presentation

In this week's "Rising High," The Fly's recurring series focused on cannabis and psychedelic stock news, The Fly looks back on earnings, a Phase 3 ...

Rising High: Cannabis firms report quarterly earnings

AAWH

ATAI

AYRWF

CANN

CMPS

CRLBF

CRON

CVSI

CYBN

ENVB

GRWG

IMCC

MEDIF

NLCP

RLMD

SHFS

TCNNF

TLRY

VREOF

Press Releases

IM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement

IM Cannabis to Report Second Quarter 2024 Financial Results on Wednesday, August 14th at 9:00am ET

Earnings

IM Cannabis Reports Second Quarter Financial Results

Small Cap

IM Cannabis Announces Appointment of Shmulik Arbel to Board of Directors

Mutual Funds

Markets

IMC Germany Announces Outstanding Preliminary Q3, 2024 Performance with 50% Growth Over Q2

Offerings

IM Cannabis Announces up to US$1,613,000 Private Placement Offering Led by Management

IM Cannabis to Report Third Quarter 2024 Financial Results on Thursday, November 14th at 9:00am ET

IM Cannabis Closes Non-Brokered Private Placement led by Management and Concurrent Debt Settlement

IM Cannabis Reports Third Quarter Financial Results

CSE:IMCC

Comments

IM Cannabis

IM Cannabis (IMCC) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO